Top news
FDA, CDC lift pause on J&J Covid vaccinations
By Erika Edwards & Sara G. Miller
Congressional investigation launched into Emergent BioSolutions' federal vaccine contracts
By Rich Mendez
FDA report finds multiple failings at plant that ruined 15 million Johnson & Johnson vaccine doses
By Christopher Rowland
All coverage
Vaccinations are plateauing. Don't blame it on 'resistance'
By Stefanie Friedhoff
White House writes off Johnson & Johnson vaccine after string of production failures
By Sarah Owermohle, Adam Cancryn & Erin Banco
L.A. County prepping to resume administering Johnson & Johnson vaccine
By Luke Money & Colleen Shalby
U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately
By Julie Steenhuysen & Manas Mishra
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.'s request ...
By Sheryl Gay Stolberg
Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume
By Elizabeth Weise & Karen Weintraub
Johnson & Johnson Vaccine: U.S. Lifts Pause : Coronavirus Updates
By Laurel Wamsley
FDA finds poor conditions at Baltimore plant that ruined millions of doses of J&J Covid vaccine
By Berkeley Lovelace, Berkeley Lovelace Jr. & Amanda Macias
U.S. lifts pause on use of J&J's Covid-19 vaccine
By Helen Branswell
The public's concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds
By Scott Clement & Amy Goldstein